Our sister site, Drug Delivery Business News, reports today that Dexcom appointed Jon Coleman as its new CCO.
Coleman assumes responsibility for Dexcom’s global commercial organization, including global sales, marketing and customer experience. He takes over for Teri Lawver, who in October announced her plans to retire as CCO of the continuous glucose monitor (CGM) maker. At the time, Dexcom said Lawver would serve as a special advisor to the company through early 2025.
Coleman brings more than 30 years of global commercial leadership experience across multiple healthcare segments and channels. He spent 15 years at Masimo, serving as an executive officer in roles of increasing responsibility. That included leading Masimo’s commercial teams as president.
Get the full story at our sister site, Drug Delivery Business News.
